Literature DB >> 12749681

Congenital cytomegalovirus infection.

Alexander K C Leung1, Reginald S Sauve, H Dele Davies.   

Abstract

Cytomegalovirus (CMV) is the most common congenital infection in humans. Congenital CMV infection can follow either a primary or recurrent maternal infection, but the likelihood of fetal infection and the risk of associated damage is higher after a primary infection. Approximately 90% of congenitally infected infants are asymptomatic at birth. Jaundice, petechiae, and hepatosplenomegaly are the most frequently noted clinical triad in symptomatic infants. More frequent and more severe sequelae occur in symptomatic infants, notably psychomotor hearing loss and retardation. Congenital CMV infection can be diagnosed by isolation of the virus from the urine or saliva within the first three weeks of life. Rapid diagnosis can be accomplished by detection of CMV DNA by DNA amplification or hybridization techniques.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12749681      PMCID: PMC2594406     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  30 in total

1.  Severe fetal cytomegalic inclusion disease after documented maternal reactivation of cytomegalovirus infection during pregnancy.

Authors:  T Rousseau; S Douvier; I Reynaud; N Laurent; J B Bour; C Durand; G Spagnolo; P Sagot
Journal:  Prenat Diagn       Date:  2000-04       Impact factor: 3.050

Review 2.  Screening options for prevention of congenital cytomegalovirus infection.

Authors:  C Peckham; P Tookey; S Logan; C Giaquinto
Journal:  J Med Screen       Date:  2001       Impact factor: 2.136

3.  Congenital cytomegalovirus infection (CMV).

Authors:  M S Schimmel; D Fisher; Y Schlesinger
Journal:  J Perinatol       Date:  2001 Apr-May       Impact factor: 2.521

Review 4.  Cytomegalovirus infection.

Authors:  Robert F Pass
Journal:  Pediatr Rev       Date:  2002-05

5.  Can congenital CMV infection lead to intracranial hemorrhage?

Authors:  J M McDonald; T S Raghuveer; M P D'Alessandro
Journal:  J Perinatol       Date:  2001-09       Impact factor: 2.521

6.  Congenital and perinatal infections with cytomegalovirus.

Authors:  D E Trincado; W D Rawlinson
Journal:  J Paediatr Child Health       Date:  2001-04       Impact factor: 1.954

Review 7.  Congenital CMV-infection and hearing loss.

Authors:  N Lagasse; I Dhooge; P Govaert
Journal:  Acta Otorhinolaryngol Belg       Date:  2000

8.  Congenital HCMV infection: a collaborative and comparative study of virus detection in amniotic fluid by culture and by PCR.

Authors:  S Gouarin; P Palmer; D Cointe; S Rogez; A Vabret; F Rozenberg; F Denis; F Freymuth; P Lebon; L Grangeot-Keros
Journal:  J Clin Virol       Date:  2001-04       Impact factor: 3.168

Review 9.  Diagnosis and prognostic markers of HCMV infection.

Authors:  L Grangeot-Keros; D Cointe
Journal:  J Clin Virol       Date:  2001-06       Impact factor: 3.168

10.  Prenatal diagnosis of congenital cytomegalovirus infection in 189 pregnancies with known outcome.

Authors:  G Enders; U Bäder; L Lindemann; G Schalasta; A Daiminger
Journal:  Prenat Diagn       Date:  2001-05       Impact factor: 3.050

View more
  17 in total

1.  Viral binding-induced signaling drives a unique and extended intracellular trafficking pattern during infection of primary monocytes.

Authors:  Jung Heon Kim; Donna Collins-McMillen; Patrizia Caposio; Andrew D Yurochko
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-18       Impact factor: 11.205

2.  Infected T98G glioblastoma cells support human cytomegalovirus reactivation from latency.

Authors:  Shuang Cheng; Xuan Jiang; Bo Yang; Le Wen; Fei Zhao; Wen-Bo Zeng; Xi-Juan Liu; Xiao Dong; Jin-Yan Sun; Ying-Zi Ming; Hua Zhu; Simon Rayner; Qiyi Tang; Elizabeth Fortunato; Min-Hua Luo
Journal:  Virology       Date:  2017-07-24       Impact factor: 3.616

3.  iTRAQ-Based Proteomics Analysis of Human Cytomegalovirus Latency and Reactivation in T98G Cells.

Authors:  Shuang Cheng; Fei Zhao; Le Wen; Bo Yang; Xian-Zhang Wang; Sheng-Nan Huang; Xuan Jiang; Wen-Bo Zeng; Jin-Yan Sun; Fu-Kun Zhang; Hong-Jie Shen; Elizabeth Fortunato; Min-Hua Luo; Han Cheng
Journal:  J Virol       Date:  2021-11-03       Impact factor: 6.549

Review 4.  Congenital cytomegalovirus infection: new prospects for prevention and therapy.

Authors:  Elizabeth C Swanson; Mark R Schleiss
Journal:  Pediatr Clin North Am       Date:  2013-04       Impact factor: 3.278

Review 5.  Causation of permanent unilateral and mild bilateral hearing loss in children.

Authors:  Anne Marie Tharpe; Douglas P Sladen
Journal:  Trends Amplif       Date:  2008-03

6.  Roles of phosphatidylinositol 3-kinase and NF-kappaB in human cytomegalovirus-mediated monocyte diapedesis and adhesion: strategy for viral persistence.

Authors:  M Shane Smith; Elizabeth R Bivins-Smith; A Michael Tilley; Gretchen L Bentz; Gary Chan; Jessica Minard; Andrew D Yurochko
Journal:  J Virol       Date:  2007-05-16       Impact factor: 5.103

7.  Elongin B-mediated epigenetic alteration of viral chromatin correlates with efficient human cytomegalovirus gene expression and replication.

Authors:  Jiwon Hwang; Ryan T Saffert; Robert F Kalejta
Journal:  mBio       Date:  2011-03-29       Impact factor: 7.867

Review 8.  Role of human cytomegalovirus tegument proteins in virion assembly.

Authors:  Rebecca Marie Smith; Srivenkat Kosuri; Julie Anne Kerry
Journal:  Viruses       Date:  2014-02-06       Impact factor: 5.048

9.  Unusually difficult clinical presentation of an infant suffering from congenital Cytomegalovirus (CMV) infection combined with alpha 1-antitrypsin (A1AT) deficiency.

Authors:  Ines Potočnjak; Goran Tešović; Andrea Tešija Kuna; Mario Stefanović; Orjena Zaja
Journal:  Biochem Med (Zagreb)       Date:  2014-10-15       Impact factor: 2.313

10.  Comparison of the pathogenesis of the highly passaged MCMV Smith strain with that of the low passaged MCMV HaNa1 isolate in BALB/c mice upon oronasal inoculation.

Authors:  Shunchuan Zhang; Jun Xiang; Jan Van Doorsselaere; Hans J Nauwynck
Journal:  Vet Res       Date:  2015-09-04       Impact factor: 3.683

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.